Author

M. J. Pucci

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Organism:E. coli· 1 Approach:experimental assay· 1 Organism:mouse· 1

Frequent Co-Authors

N. Cotroneo· 2 shared A. Rubio· 1 shared I. A. Critchley· 1 shared I. Critchley· 1 shared K. Hamed· 1 shared R. Mendes· 1 shared S. Stokes· 1 shared

Activity by Year

2019-2022 · peak 1/yr

Co-Author Collaboration Network

7 top collaborators · 13 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

N. Cotroneo

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

In vitro activity and in vivo efficacy against non-tuberculous mycobacteria of SPR719, the active moiety of the novel oral benzimidazole prodrug SPR720

I. A. Critchley, N. Cotroneo, S. Stokes, M. J. Pucci, A. Rubio, K. Hamed

This study evaluates the in vitro activity and in vivo efficacy of SPR720 against non-tuberculous mycobacteria, showing promising results in murine models.

bioRxiv · Dec 8, 2022 · PreprintMicrobiology

The Burden of Antimicrobial Resistance among Urinary Tract Isolates of Escherichia coli in the United States in 2017

I. Critchley, N. Cotroneo, M. J. Pucci, R. Mendes

This study assesses the prevalence of ESBL phenotypes and co-resistance to oral agents in E. coli UTI isolates in the US in 2017, finding high rates of resistance and highlighting the need for new oral treatments.

bioRxiv · Jul 17, 2019Microbiology